Interpreting the Results of Systematic Reviews

Seminars in Hematology

Volumn 45, Issue 3, 2008, Pages 176-180

  Clarke, Mike ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; RITUXIMAB;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; B CELL LYMPHOMA; BONE MARROW TRANSPLANTATION; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL RESEARCH; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; HEALTH CARE; HUMAN; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL LITERATURE; META ANALYSIS; MYELOMA; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SYSTEMATIC REVIEW;

DECISION MAKING; HUMANS; RESEARCH;

EID: 45749158544     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2008.04.002     Document Type: Article

References (28)

1. Childhood ALL Collaborative Group. Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12,000 randomised children. Lancet 347 (1996) 1783-1788
2. Clarke M., Gaynon P., Hann I., Harrison G., Masera G., Peto R., et al. CNS-directed therapy for childhood acute lymphoblastic leukaemia: Childhood ALL Collaborative Group overview of 43 randomized trials. J Clin Oncol 21 (2003) 1798-1809
3. Green H., Paul M., Vidal L., and Leibovici L. Prophylaxis for pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database of Systematic Reviews Issue 3 (2007) CD005590
4. Moher D., Tetzlaff J., Tricco A.C., Sampson M., and Altman D.G. Epidemiology and reporting characteristics of systematic reviews. PLoS Med 4 (2007) e78
5. Weingart O., Kober T., Engert A., Diehl V., Djulbegovic B., Glasmacher A., et al., Cochrane Haematological Malignancies Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) Issue 2:Art. No.: HAEMATOL (2006)
6. El Dib R.P., Atallah A.N., and Andriolo R.B. Mapping the Cochrane evidence for decision making in health care. J Eval Clin Pract 13 (2007) 689-692
7. Clarke L., Clarke M., and Clarke T. Implications for research from Cochrane reviews. J Health Services Res Policy 12 (2007) 101-103
8. Clarke M. Doing new research?. Don't forget the old: Nobody should do a trial without reviewing what is known. PLoS Med 1 (2004) 100-102
9. Brown P., Brunnhuber K., Chalkidou K., Chalmers I., Clarke M., Fenton M., et al. How to formulate research recommendations. BMJ 333 (2006) 804-806
10. Mulrow C. The medical review article: state of the science. Ann Intern Med 106 (1987) 485-488
11. In: Khan K.S., ter Riet G., Glanville J., Sowden A.J., and Kleijnen J. (Eds). Undertaking Systematic Reviews of Research on Effectiveness. ed 2 (2001), NHS Centre for Reviews and Dissemination, University of York, York, UK
12. In: Higgins J.P.T., and Green S. (Eds). Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 (2006). http://www.cochrane.org/resources/handbook/hbook.htm (accessed December 6, 2007)
13. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., and Stroup D.F. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Lancet 354 (1999) 1896-1900
14. Katrak P., Bialocerkowski A.E., Massy-Westropp N., Kumar S., and Grimmer K.A. A systematic review of the content of critical appraisal tools. BMC Med Res Methodol 4 (2004) 22
15. Oxman A.D., and Guyatt G.H. Validation of an index of the quality of review articles. J Clin Epidemiol 44 (1991) 1271-1278
16. Oxman A.D. Checklists for review articles. BMJ 309 (1994) 648-651
17. Shea B.J., Boers M., Grimshaw J.M., Hamel C.D., and Bouter L.M. Does updating improve the methodological and reporting quality of systematic reviews?. BMC Med Res Methodol 6 (2006) 27
18. Sacks H., Berrier J., Reitman D., Ancona-Berk V.A., and Chalmers T.C. Meta-analyses of randomized controlled trials. N Engl J Med 316 (1987) 450-455
19. Shea B., Moher D., Graham I., Pham B., and Tugwell P. A comparison of the quality of Cochrane reviews and systematic reviews published in paper-based journals. Evaluation Health Professions 25 (2002) 116-129
20. Shojania K.G., Sampson M., Ansari M.T., Doucette S., and Moher D. How quickly do systematic reviews go out of date?. A survival analysis. Ann Intern Med 147 (2007) 224-233
21. Hopewell S., Clarke M., Stewart L., and Tierney J. Time to publication for results of clinical trials. Cochrane Database of Systematic Reviews 2 (2007) MR000011
22. Guyatt G.H., Sackett D.L., Cook D.J., and Evidence-Based Medicine Working Group. Users' guides to the medical literature, II: How to use an article about therapy or prevention, B: What were the results and will they help me in caring for my patients. JAMA 271 (1994) 59-63
23. Yusuf S., Wittes J., Probstfield J., and Tyroler H.A. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 266 (1991) 93-98
24. Oxman A.D., and Guyatt G.H. A consumer's guide to subgroup analyses. Ann Intern Med 116 (1992) 78-84
25. Counsell C.E., Clarke M.J., Slattery J., and Sandercock P.A.G. The miracle of DICE therapy for acute stroke: Fact or fictional product of subgroup analysis?. BMJ 309 (1994) 1677-1681
26. Myeloma Trialists Collaborative Group. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials. J Clin Oncol 16 (1998) 3832-3842
27. Deeks J.J., and Altman D.G. Effect measures for meta-analysis of trials with binary outcomes. In: Egger M., Davey Smith G., and Altman D.G. (Eds). Systematic Reviews in Health Care. ed 2 (2001), BMJ Publishing Group, London, UK 313-335
28. Schulz H., Bohlius J., Skoetz N., Trelle S., Kober T., Reiser M., et al. Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma. Cochrane Database of Systematic Reviews 4 (2007) CD003805